Next Article in Journal
The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation
Next Article in Special Issue
Neuroinflammation in Primary Open-Angle Glaucoma
Previous Article in Journal
Methodological Considerations for Neuroimaging in Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease Patients
Previous Article in Special Issue
Computational Analysis of Clinical and Molecular Markers and New Theranostic Possibilities in Primary Open-Angle Glaucoma
 
 
Article
Peer-Review Record

Diffusional Kurtosis Imaging of White Matter Degeneration in Glaucoma

J. Clin. Med. 2020, 9(10), 3122; https://doi.org/10.3390/jcm9103122
by Carlo Nucci 1,*, Francesco Garaci 2,3,*, Simone Altobelli 4, Francesco Di Ciò 4, Alessio Martucci 1, Francesco Aiello 1, Simona Lanzafame 4, Francesca Di Giuliano 2, Eliseo Picchi 4,5, Silvia Minosse 4, Massimo Cesareo 1, Maria Giovanna Guerrisi 4, Roberto Floris 5, Luca Passamonti 6,7,* and Nicola Toschi 4,8
Reviewer 1: Anonymous
Reviewer 2: Anonymous
J. Clin. Med. 2020, 9(10), 3122; https://doi.org/10.3390/jcm9103122
Submission received: 24 July 2020 / Revised: 18 September 2020 / Accepted: 23 September 2020 / Published: 27 September 2020
(This article belongs to the Special Issue Update on Glaucoma: Pathogenesis and Treatment)

Round 1

Reviewer 1 Report

The study has evaluated the use of Kurtosis imaging (DKI) in patients with glaucoma. The results obtained indicate that this technique, compared to the DTI indices, provides further information about the white matter abnormalities of glaucoma patients. 
The study was properly structured. The discussion is relevant and exhaustive. The iconography is of excellent quality and very explanatory. The references  are complete.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

While this paper appears interesting and potentially important, authors are advised to address few issues below before this paper can be considered for publication:

(1) What was the duration of the DKI scans? Can authors discuss in more detail its applicability toward clinical use?

(2) Is there any major advantage of DKI over DTI in detecting glaucoma changes from the current data presented? E.g. Is KA or MK more sensitive or specific than FA? How about AK from DKI vs axial diffusivity from DTI, and RK from DKI vs radial diffusivity from DTI?

(3) Was there any correlation between DKI/DTI metrics and the severity of disease based on the staging classifications or from the clinical ophthalmic assessments performed (e.g. visual field function, corneal thickness etc?)

(4) The authors are advised to discuss how their TBSS results using DTI and DKI are similar to or different from recent TBSS studies in glaucoma with DTI (e.g. PMID 24901535, 27510406, 31578409)

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop